share_log

Shenzhen RongDa Photosensitive Science & Technology's (SZSE:300576) Five-year Earnings Growth Trails the Splendid Shareholder Returns

Shenzhen RongDa Photosensitive Science & Technology's (SZSE:300576) Five-year Earnings Growth Trails the Splendid Shareholder Returns

深圳容大光敏科技(SZSE: 300576)的五年收益增長落後於豐厚的股東回報
Simply Wall St ·  02/19 18:26

Shenzhen RongDa Photosensitive Science & Technology Co., Ltd. (SZSE:300576) shareholders might be concerned after seeing the share price drop 29% in the last quarter. But that doesn't change the fact that shareholders have received really good returns over the last five years. In fact, the share price is 275% higher today. We think it's more important to dwell on the long term returns than the short term returns. The more important question is whether the stock is too cheap or too expensive today.

深圳容大光敏科技股份有限公司(SZSE: 300576)股東在看到上個季度股價下跌29%後可能會感到擔憂。但這並不能改變股東在過去五年中獲得了非常不錯的回報的事實。實際上,今天的股價上漲了275%。我們認爲,關注長期回報比短期回報更重要。更重要的問題是今天的股票是太便宜還是太昂貴。

The past week has proven to be lucrative for Shenzhen RongDa Photosensitive Science & Technology investors, so let's see if fundamentals drove the company's five-year performance.

事實證明,過去一週對深圳融達光敏科技投資者來說是有利可圖的,所以讓我們看看基本面是否推動了該公司的五年業績。

To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

引用巴菲特的話說:“船隻將在世界各地航行,但Flat Earth Society將蓬勃發展。市場上的價格和價值之間將繼續存在巨大差異...”研究市場情緒如何隨着時間的推移而變化的一種方法是研究公司股價與其每股收益(EPS)之間的相互作用。

Over half a decade, Shenzhen RongDa Photosensitive Science & Technology managed to grow its earnings per share at 19% a year. This EPS growth is slower than the share price growth of 30% per year, over the same period. So it's fair to assume the market has a higher opinion of the business than it did five years ago. And that's hardly shocking given the track record of growth. This favorable sentiment is reflected in its (fairly optimistic) P/E ratio of 82.02.

在過去的五年中,深圳榮達光敏科技成功地將每股收益增長到每年19%。每股收益的增長低於同期每年30%的股價增長。因此,可以公平地假設市場對該業務的看法比五年前更高。考慮到增長的記錄,這並不令人震驚。這種積極情緒反映在其(相當樂觀的)市盈率82.02上。

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

你可以在下面看到 EPS 是如何隨着時間的推移而變化的(點擊圖片發現確切的值)。

earnings-per-share-growth
SZSE:300576 Earnings Per Share Growth February 19th 2024
深圳證券交易所:300576 每股收益增長 2024 年 2 月 19 日

Dive deeper into Shenzhen RongDa Photosensitive Science & Technology's key metrics by checking this interactive graph of Shenzhen RongDa Photosensitive Science & Technology's earnings, revenue and cash flow.

查看這張深圳容大光敏科技收益、收入和現金流的交互式圖表,深入了解深圳容大光敏科技的關鍵指標。

What About Dividends?

分紅呢?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. We note that for Shenzhen RongDa Photosensitive Science & Technology the TSR over the last 5 years was 279%, which is better than the share price return mentioned above. This is largely a result of its dividend payments!

重要的是要考慮任何給定股票的股東總回報率和股價回報率。儘管股價回報率僅反映股價的變化,但股東總回報率包括股息的價值(假設已進行再投資)以及任何折扣融資或分拆的收益。可以公平地說,股東總回報率爲支付股息的股票提供了更完整的畫面。我們注意到,深圳容大光敏科技在過去5年的股東總回報率爲279%,好於上述股價回報率。這在很大程度上是其股息支付的結果!

A Different Perspective

不同的視角

It's good to see that Shenzhen RongDa Photosensitive Science & Technology has rewarded shareholders with a total shareholder return of 53% in the last twelve months. That's including the dividend. That's better than the annualised return of 31% over half a decade, implying that the company is doing better recently. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Even so, be aware that Shenzhen RongDa Photosensitive Science & Technology is showing 2 warning signs in our investment analysis , and 1 of those is concerning...

很高興看到深圳容大光敏科技在過去十二個月中向股東提供了53%的總股東回報率。這包括股息。這比五年來31%的年化回報率要好,這意味着該公司最近的表現更好。持樂觀態度的人可能會將最近股東總回報率的改善視爲業務本身隨着時間的推移而變得更好。儘管市場狀況可能對股價產生的不同影響值得考慮,但還有其他因素更爲重要。即便如此,請注意,深圳容大光敏科技在我們的投資分析中顯示出兩個警告信號,其中一個是令人擔憂的...

We will like Shenzhen RongDa Photosensitive Science & Technology better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我們看到一些重大的內幕收購,我們會更喜歡深圳榮達光敏科技。在我們等待的同時,請查看這份免費清單,列出了最近有大量內幕收購的成長型公司。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論